Corbus Pharmaceuticals Holdings (CRBP) Net Cash Flow (2013 - 2025)

Corbus Pharmaceuticals Holdings' Net Cash Flow history runs 13 years deep, the most recent figure standing at $6.9 million for Q3 2025.

• In Q3 2025, Net Cash Flow rose 262.77% year-over-year to $6.9 million; the TTM figure through Dec 2025 stood at $9.8 million (up 181.66% YoY), while the FY2024 annual figure was $3.5 million, up 205.95% from the prior year.
• Net Cash Flow was $6.9 million for Q3 2025 at Corbus Pharmaceuticals Holdings, up from $1.1 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $32.0 million in Q1 2022 to a low of -$31.3 million in Q2 2022.
• Historically, Net Cash Flow has averaged -$3.1 million across 5 years, with a median of $1.0 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Net Cash Flow slumped 1383.47% in 2022, then jumped 835.59% in 2024.
• A 5-year view of Net Cash Flow shows it stood at -$12.1 million in 2021, then surged by 137.64% to $4.6 million in 2022, then sank by 45.71% to $2.5 million in 2023, then sank by 189.9% to -$2.2 million in 2024, then soared by 411.87% to $6.9 million in 2025.
• The last three Net Cash Flow figures came in at $6.9 million (Q3 2025), $1.1 million (Q2 2025), and $1.7 million (Q1 2025), per Business Quant data.